Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shuganhuazhuo Formula (Chinese Herbal Medicine) in the Combined Treatment of Advanced Hepatocellular Carcinoma With Damp-Heat and Blood Stasis Syndrome: An Open-Label Randomized Controlled Trial

NCT07691645 is registered in ClinicalTrials.gov with Xiang-Qian as lead sponsor.

NCT NCT07691645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07691645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shuganhuazhuo Formula (Chinese Herbal Medicine) in the Combined Treatment of Advanced Hepatocellular Carcinoma With Damp-Heat and Blood Stasis Syndrome: An Open-Label Randomized Controlled Trial
Lead sponsor
Xiang-Qian
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2027
Completion date
August 31, 2032
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chinese herbal medicine, hcc - hepatocellular carcinoma, icg (indocyanine green), overall survival (all-cause mortality), quality of life